BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31326731)

  • 21. Current advances in the management of malignant germ cell and sex cord-stromal tumors of the ovary.
    Gershenson DM
    Gynecol Oncol; 2012 Jun; 125(3):515-7. PubMed ID: 22426486
    [No Abstract]   [Full Text] [Related]  

  • 22. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
    Wang J; Li J; Chen R; Lu X
    Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian cancer during pregnancy.
    Gezginç K; Karataylı R; Yazıcı F; Acar A; Celik C; Capar M
    Int J Gynaecol Obstet; 2011 Nov; 115(2):140-3. PubMed ID: 21872237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer.
    Hemmingsen CH; Kjaer SK; Bennetsen AKK; Dehlendorff C; Baandrup L
    Gynecol Oncol; 2021 Aug; 162(2):469-474. PubMed ID: 34016454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes.
    Sköld C; Koliadi A; Enblad G; Stålberg K; Glimelius I
    Int J Cancer; 2022 Mar; 150(5):773-781. PubMed ID: 34648676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian sex cord stromal tumours in children and young girls - a more than two decade clinicopathological experience in a developing country, Pakistan.
    Haroon S; Idrees R; Zia A; Memon A; Fatima S; Kayani N
    Asian Pac J Cancer Prev; 2014; 15(3):1351-5. PubMed ID: 24606464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects.
    Boussios S; Moschetta M; Zarkavelis G; Papadaki A; Kefas A; Tatsi K
    Crit Rev Oncol Hematol; 2017 Dec; 120():43-51. PubMed ID: 29198337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and treatment outcomes of ovarian sarcoma compared to epithelial ovarian cancer from the national cancer registry.
    Ha HI; Cho SH; Lim J; Lee YJ; Yoo CW; Won YJ; Lim MC
    Gynecol Oncol; 2021 Dec; 163(3):506-510. PubMed ID: 34602286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The multidisciplinary approach to ovarian tumours in children and adolescents.
    van Heerden J; Tjalma WA
    Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():103-110. PubMed ID: 31683108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Colombo N; Peiretti M; Garbi A; Carinelli S; Marini C; Sessa C;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii20-6. PubMed ID: 22997450
    [No Abstract]   [Full Text] [Related]  

  • 31. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993.
    Bjørge T; Engeland A; Hansen S; Tropé CG
    Int J Cancer; 1997 May; 71(5):780-6. PubMed ID: 9180146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidences of malignant gonadal and extragonadal germ cell tumors in males and females: a population-based study covering over 40 years in Finland.
    Pauniaho SL; Salonen J; Helminen M; Vettenranta K; Heikinheimo M; Heikinheimo O
    Cancer Causes Control; 2012 Dec; 23(12):1921-7. PubMed ID: 23011538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological pattern of ovarian neoplasma.
    Ahmad Z; Kayani N; Hasan SH; Muzaffar S; Gill MS
    J Pak Med Assoc; 2000 Dec; 50(12):416-9. PubMed ID: 11191442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian tumours in childhood and adolescence.
    Hatzipantelis ES; Dinas K
    Eur J Gynaecol Oncol; 2010; 31(6):616-20. PubMed ID: 21319502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).
    Solheim O; Kærn J; Tropé CG; Rokkones E; Dahl AA; Nesland JM; Fosså SD
    Gynecol Oncol; 2013 Nov; 131(2):330-5. PubMed ID: 24001518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients.
    Ray-Coquard I; Weber B; Lotz JP; Tournigand C; Provencal J; Mayeur D; Treilleux I; Paraiso D; Duvillard P; Pujade-Lauraine E;
    Gynecol Oncol; 2010 Oct; 119(1):53-9. PubMed ID: 20580063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of E-cadherin and catenins in ovarian sex cord stromal tumours.
    Stavrinou S; Clark A; Irving J; Lee CH; Oliva E; Young R; Sriraksa R; Magdy N; Van Noorden S; McCluggage WG; El-Bahrawy M
    Histopathology; 2016 Aug; 69(2):298-306. PubMed ID: 27097978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
    Zhang C; Xi X
    Oncol Res Treat; 2023; 46(11):476-492. PubMed ID: 37857263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the histogenesis of mixed germ cell-sex cord stromal tumour of the gonads.
    Roth LM; Cheng L
    J Clin Pathol; 2017 Mar; 70(3):222-227. PubMed ID: 27458149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymph-node metastasis in stage I and II sex cord stromal and malignant germ cell tumours of the ovary: a systematic review.
    Kleppe M; Amkreutz LC; Van Gorp T; Slangen BF; Kruse AJ; Kruitwagen RF
    Gynecol Oncol; 2014 Apr; 133(1):124-7. PubMed ID: 24440833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.